Ginkgo Bioworks Announces Participation in the 43rd Annual J.P. Morgan Healthcare Conference
Ginkgo Bioworks (NYSE: DNA), a company focused on cell programming and biosecurity, announced that its Co-Founder and CEO Jason Kelly will present at the 43rd Annual J.P. Morgan Healthcare Conference. The presentation is scheduled for Thursday, January 16, 2025, at 10:30 a.m. PT (1:30 p.m. ET). A webcast link and replay will be available on the company's investor relations website.
Ginkgo Bioworks (NYSE: DNA), un'azienda specializzata nella programmazione cellulare e nella biosicurezza, ha annunciato che il suo co-fondatore e CEO Jason Kelly presenterà alla 43ª Conferenza Annuale J.P. Morgan Healthcare. La presentazione è prevista per giovedì 16 gennaio 2025, alle 10:30 PT (13:30 ET). Un link per la diretta web e il replay saranno disponibili sul sito web delle relazioni con gli investitori dell'azienda.
Ginkgo Bioworks (NYSE: DNA), una empresa centrada en la programación celular y la bioseguridad, anunció que su cofundador y CEO Jason Kelly presentará en la 43ª Conferencia Anual de J.P. Morgan Healthcare. La presentación está programada para el jueves 16 de enero de 2025, a las 10:30 a.m. PT (1:30 p.m. ET). Un enlace para la transmisión en vivo y la repetición estarán disponibles en el sitio web de relaciones con inversores de la empresa.
징코 바이오웍스(Ginkgo Bioworks)(NYSE: DNA)는 세포 프로그래밍과 생물안전에 중점을 둔 회사로, 공동 창립자이자 CEO인 제이슨 켈리가 제43회 JP모건 헬스케어 콘퍼런스에서 발표한다고 발표했습니다. 발표는 2025년 1월 16일 목요일 오전 10시 30분 PT(오후 1시 30분 ET)에 예정되어 있습니다. 웹캐스트 링크와 재생은 회사의 투자자 관계 웹사이트에서 이용할 수 있습니다.
Ginkgo Bioworks (NYSE: DNA), une entreprise axée sur la programmation cellulaire et la biosécurité, a annoncé que son co-fondateur et PDG, Jason Kelly, présentera lors de la 43ème Conférence Annuelle J.P. Morgan Healthcare. La présentation est prévue pour le jeudi 16 janvier 2025, à 10h30 PT (13h30 ET). Un lien pour la diffusion en direct et la rediffusion sera disponible sur le site internet des relations investisseurs de l'entreprise.
Ginkgo Bioworks (NYSE: DNA), ein Unternehmen, das sich auf Zellprogrammierung und Biosicherheit konzentriert, gab bekannt, dass sein Mitgründer und CEO Jason Kelly auf der 43. jährlichen J.P. Morgan Healthcare-Konferenz präsentieren wird. Die Präsentation ist für Donnerstag, den 16. Januar 2025, um 10:30 Uhr PT (13:30 Uhr ET) angesetzt. Ein Link zur Webcast-Übertragung und eine Wiederholung werden auf der Website für Investor Relations des Unternehmens verfügbar sein.
- None.
- None.
Further details, a webcast link, and a replay of the presentation will be posted on the company's investor relations website at https://investors.ginkgobioworks.com/events.
About Ginkgo Bioworks
Ginkgo Bioworks is the leading horizontal platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. Ginkgo Biosecurity is building and deploying the next-generation infrastructure and technologies that global leaders need to predict, detect, and respond to a wide variety of biological threats. For more information, visit ginkgobioworks.com and ginkgobiosecurity.com, read our blog, or follow us on social media channels such as X (@Ginkgo and @Ginkgo_Biosec), Instagram (@GinkgoBioworks), Threads (@GinkgoBioworks), or LinkedIn.
Ginkgo Bioworks Contacts:
INVESTOR CONTACT:
investors@ginkgobioworks.com
MEDIA CONTACT:
press@ginkgobioworks.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/ginkgo-bioworks-announces-participation-in-the-43rd-annual-jp-morgan-healthcare-conference-302346539.html
SOURCE Ginkgo Bioworks
FAQ
When is Ginkgo Bioworks (DNA) presenting at the 2025 J.P. Morgan Healthcare Conference?
Where can investors watch Ginkgo Bioworks' (DNA) J.P. Morgan Healthcare Conference presentation?
Who will represent Ginkgo Bioworks (DNA) at the 2025 J.P. Morgan Healthcare Conference?
Which annual J.P. Morgan Healthcare Conference is Ginkgo Bioworks (DNA) participating in for 2025?
